Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis

Journal of the Neurological Sciences

Volumn 348, Issue 1-2, 2015, Pages 174-180

  Tang, Shao Can ^a   Fan, Xiao Hua ^a   Pan, Qing Min ^a,b   Sun, Qiang San ^c   Liu, Yu ^d  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d QILU UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

CD4+ T cells; Cytokines; Interleukin 27; Progressive multiple sclerosis; T helper 1; T helper 17

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 27; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; ADOLESCENT; BLOOD; LYMPHOCYTE COUNT; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; INTERLEUKIN-27; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84920940028     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.11.035     Document Type: Article

References (48)

1. C.P. Kamm, B.M. Uitdehaag, and C.H. Polman Multiple sclerosis: current knowledge and future outlook Eur Neurol 72 2014 132 141
2. M.J. Tullman Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis Am J Manag Care 19 2013 S15 S20
3. F. Jadidi-Niaragh, and A. Mirshafiey Th17 cell, the new player of neuroinflammatory process in multiple sclerosis Scand J Immunol 74 2011 1 13
4. J.M. Fletcher, S.J. Lalor, C.M. Sweeney, N. Tubridy, and K.H. Mills T cells in multiple sclerosis and experimental autoimmune encephalomyelitis Clin Exp Immunol 162 2010 1 11
5. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, and Y.H. Wang A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 2005 1133 1141
6. T. Aranami, and T. Yamamura Th17 Cells and autoimmune encephalomyelitis (EAE/MS) Allergol Int: Off J Jpn Soc Allergol 57 2008 115 120
7. A. Di Cesare, P. Di Meglio, and F.O. Nestle The IL-23/Th17 axis in the immunopathogenesis of psoriasis J Invest Dermatol 129 2009 1339 1350
8. J. Leipe, M. Grunke, C. Dechant, C. Reindl, U. Kerzendorf, and H. Schulze-Koops Role of Th17 cells in human autoimmune arthritis Arthritis Rheum 62 2010 2876 2885
9. A.E. Lovett-Racke, Y. Yang, and M.K. Racke Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 2011 1812 246 251
10. S. Pflanz, J.C. Timans, J. Cheung, R. Rosales, H. Kanzler, and J. Gilbert IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 + T cells Immunity 16 2002 779 790
11. M. Batten, and N. Ghilardi The biology and therapeutic potential of interleukin 27 J Mol Med (Berl) 85 2007 661 672
12. A. Takeda, S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, and T.W. Mak Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment J Immunol 170 2003 4886 4890
13. T. Owaki, M. Asakawa, N. Morishima, K. Hata, F. Fukai, and M. Matsui A role for IL-27 in early regulation of Th1 differentiation J Immunol 175 2005 2191 2200
14. A. Awasthi, Y. Carrier, J.P. Peron, E. Bettelli, M. Kamanaka, and R.A. Flavell A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells Nat Immunol 8 2007 1380 1389
15. J.S. Stumhofer, A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, and L.M. Johnson Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system Nat Immunol 7 2006 937 945
16. M. Batten, J. Li, S. Yi, N.M. Kljavin, D.M. Danilenko, and S. Lucas Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nat Immunol 7 2006 929 936
17. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2005 233 240
18. A.B. Pernis Th17 cells in rheumatoid arthritis and systemic lupus erythematosus J Intern Med 265 2009 644 652
19. T.T. Li, T. Zhang, G.M. Chen, Q.Q. Zhu, J.H. Tao, and H.F. Pan Low level of serum interleukin 27 in patients with systemic lupus erythematosus J Investig Med: Off Publ Am Fed Clin Res 58 2010 737 739
20. Y. Cao, P.D. Doodes, T.T. Glant, and A. Finnegan IL-27 induces a Th1 immune response and susceptibility to experimental arthritis J Immunol 180 2008 922 930
21. C.K. Wong, P. Chen da, L.S. Tam, E.K. Li, Y.B. Yin, and C.W. Lam Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis Arthritis Res Ther 12 2010 R129
22. X.G. Liu, J. Ren, Y. Yu, L. Sun, Y. Shi, and P. Qin Decreased expression of interleukin-27 in immune thrombocytopenia Br J Haematol 153 2011 259 267
23. M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 30 2002 e36
24. Z. Babaloo, R.K. Yeganeh, M. Farhoodi, B. Baradaran, M. Bonyadi, and L. Aghebati Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis Iran J Immunol 10 2013 47 54
25. H.S. Panitch, R.L. Hirsch, A.S. Haley, and K.P. Johnson Exacerbations of multiple sclerosis in patients treated with gamma interferon Lancet 1 1987 893 895
26. A. Nylander, and D.A. Hafler Multiple sclerosis J Clin Invest 122 2012 1180 1188
27. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, and H. Garren Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat Med 8 2002 500 508
28. T. Ishizu, M. Osoegawa, F.J. Mei, H. Kikuchi, M. Tanaka, and Y. Takakura Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis Brain: J Neurol 128 2005 988 1002
29. H. Kebir, I. Ifergan, J.I. Alvarez, M. Bernard, J. Poirier, and N. Arbour Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis Ann Neurol 66 2009 390 402
30. A.L. Duarte, A.T. Dantas, H. de Ataide Mariz, F.A. dos Santos, J.C. da Silva, and L.F. da Rocha Jr. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients Mol Biol Rep 40 2013 4889 4892
31. S. Shibata, Y. Tada, N. Kanda, K. Nashiro, M. Kamata, and M. Karakawa Possible roles of IL-27 in the pathogenesis of psoriasis J Invest Dermatol 130 2010 1034 1039
32. D.C. Fitzgerald, B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, and J. Das Sarma Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis J Immunol 179 2007 3268 3275
33. D.C. Fitzgerald, G.X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, and S. Yu Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells Nat Immunol 8 2007 1372 1379
34. N. Grigoriadis, S. Grigoriadis, E. Polyzoidou, I. Milonas, and D. Karussis Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction Clin Neurol Neurosurg 108 2006 241 244
35. B. Cannella, and C.S. Raine The adhesion molecule and cytokine profile of multiple sclerosis lesions Ann Neurol 37 1995 424 435
36. A. Windhagen, D.E. Anderson, A. Carrizosa, K. Balashov, H.L. Weiner, and D.A. Hafler Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis J Neuroimmunol 91 1998 1 9
37. T. Yoshimura, A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, and T. Ishibashi Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4 + T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4 + T cells partially through STAT3-dependent mechanism J Immunol 177 2006 5377 5385
38. D. Matusevicius, P. Kivisakk, B. He, N. Kostulas, V. Ozenci, and S. Fredrikson Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis Mult Scler 5 1999 101 104
39. H. Kebir, K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, and M. Bernard Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation Nat Med 13 2007 1173 1175
40. G. Murugaiyan, A. Mittal, R. Lopez-Diego, L.M. Maier, D.E. Anderson, and H.L. Weiner IL-27 is a key regulator of IL-10 and IL-17 production by human CD4 + T cells J Immunol 183 2009 2435 2443
41. G. Frisullo, V. Nociti, R. Iorio, A.K. Patanella, A. Marti, and M. Caggiula IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis Cytokine 44 2008 22 25
42. H.L. Weiner, and J.A. Cohen Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects Mult Scler 8 2002 142 154
43. J. He, R.I. Grossman, Y. Ge, and L.J. Mannon Enhancing patterns in multiple sclerosis: evolution and persistence AJNR Am J Neuroradiol 22 2001 664 669
44. J. Romme Christensen, L. Börnsen, R. Ratzer, F. Piehl, M. Khademi, and T. Olsson Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression PLoS One 8 2013 e57820
45. M. Cristofanilli, H. Rosenthal, B. Cymring, D. Gratch, B. Pagano, and B. Xie Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice Exp Neurol 261 2014 620 632
46. B. Yamout, R. Alroughani, M. Al-Jumah, S. Khoury, N. Abouzeid, and M. Dahdaleh Consensus guidelines for the diagnosis and treatment of multiple sclerosis Curr Med Res Opin 29 2013 611 621
47. R. Tanasescu, C. Ionete, I.J. Chou, and C.S. Constantinescu Advances in the treatment of relapsing-remitting multiple sclerosis Biomed J 37 2014 41 49
48. D.M. Wingerchuk, and J.L. Carter Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies Mayo Clin Proc 89 2014 225 240